Search Results - "Dahunsi, Debolanle O."
-
1
Low-Salt Diet Reduces Anti-CTLA4 Mediated Systemic Immune-Related Adverse Events while Retaining Therapeutic Efficacy against Breast Cancer
Published in Biology (Basel, Switzerland) (25-05-2022)“…Immune checkpoint inhibitor (ICI) therapy has revolutionized the breast cancer treatment landscape. However, ICI-induced systemic inflammatory immune-related…”
Get full text
Journal Article -
2
Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response
Published in Immunity (Cambridge, Mass.) (13-04-2021)“…Memory T cells are thought to rely on oxidative phosphorylation and short-lived effector T cells on glycolysis. Here, we investigated how T cells arrive at…”
Get full text
Journal Article -
3
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation
Published in The Journal of immunology (1950) (15-03-2021)“…T effector cells promote inflammation in asthmatic patients, and both Th2 and Th17 CD4 T cells have been implicated in severe forms of the disease. The…”
Get full text
Journal Article -
4
Systems Immunology Analyses of STAT1 Gain-of-Function Immune Phenotypes Reveal Heterogeneous Response to IL-6 and Broad Immunometabolic Roles for STAT1
Published in ImmunoHorizons (15-07-2022)“…Patients with gain-of-function (GOF) pathogenic variants have enhanced or prolonged STAT1 phosphorylation following cytokine stimulation and exhibit increased…”
Get full text
Journal Article -
5
Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-Talk
Published in ImmunoHorizons (01-12-2022)“…Hematopoiesis integrates cytokine signaling, metabolism, and epigenetic modifications to regulate blood cell generation. These processes are linked, as…”
Get full text
Journal Article -
6
Metabolic characteristics of Th2 and Th17 cells drive airway inflammation
Published in The Journal of immunology (1950) (01-05-2020)“…Asthma is an airway inflammatory disease that is mediated by T effector (Teff) cells, specifically Th2 and Th17 cells. Increases in disease severity leading to…”
Get full text
Journal Article